ClinicalTrials.govpublic full text
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
relapsing multiple sclerosis, ada, genetic polymorphism, immune-reconstitution therapy, 2-cda, single nucleotide polymorphisms, lymphopenia induced by 2-cda treatment, ada genetic variant rs244072, non-risk/risk allele t/c, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853548
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.